Search Results

You searched for : octapharma

	Positive Results From ProDERM Study of octagamÂ® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020 Octapharma announces that the final results from the phase III ProDERM study will be presented at the American College of Rheumatology (ACR) Convergence 2020 virtual ... Nov 07
	Octapharma announces FDA approval of updated NUWIQÂ® Prescribing Information to include immunogenicity data in previously untreated patients The development of inhibitors against exogenous FVIII can reduce the effectiveness of treatment and negatively impact a patient's long-term joint health and quality ... Oct 20
	Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019 Octapharma has seven R&D sites and six state-of-the-art manufacturing facilities in Austria, France, Germany, Mexico and Sweden, in addition to more ... Feb 17
	Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders Octapharma demonstrates commitment to improving haemophilia, a treatment at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)... Feb 08
	Update of Summary of Product Characteristics for NuwiqÂ® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis Octapharma announced today that the European Medicines Agency has authorised an updated Summary of Product Characteristics (SmPC) for NuwiqÂ® that includes information on personalised prophylaxis ... Oct 01
5 Matching result(s) found!

-Advertisements-

Trending Now
	Moscow Outpatient Departments to Implement AI X-ray InterpretationMay 31, 2024
	FLO launched Digital Ready Reckoner - of MSME schemes.May 31, 2024
	Candy flavoured traps to hook the next generationMay 31, 2024
	Software Engineering Research Centre (SERC) at IIIT H to host 21st Edition of IEEE International Conference on Software Architecture (ICSA) 2024May 31, 2024
	Federal Bank and Tata AIA Life Insurance Announce Strategic Bancassurance PartnershipMay 31, 2024
	Why Whole Spices are Better than Powdered: New ICMR GuidelinesMay 31, 2024
	Raising Awareness on Menstrual Health: NCW and SheWings Initiative on Menstrual Hygiene DayMay 31, 2024
	Innovative RNA Drugs Offer Hope for Patients with High CholesterolMay 31, 2024
	Advani Hotels & Resorts (India) Limited (Caravela Beach Resort, Goa)May 30, 2024
	FLO Hyderabad launches ‘Centre of Excellence for Training Women Vegetable Farming’May 30, 2024
	Should Doctors Be Exempt from the Consumer Protection Act? A Complex DebateMay 30, 2024
	Tamil Nadu Doctors Save 14-Year-Old Girl by Removing Needle from Lung with BronchoscopyMay 30, 2024
	The Lifesaving Journey of a Florist: Rare 'Bombay' Blood Group Donation Saves Life May 30, 2024
	The Impact of Heat on Eye Health: Preventing Eye Strokes During High TemperaturesMay 30, 2024
	Patients with super morbid obesity can find life-changing benefits beyond weight reduction through bariatric surgeryMay 29, 2024
	AI software could revolutionise voice box cancer treatmentMay 29, 2024
	Why You’re Waking Up to Pee: The Link Between Enlarged Prostate and NocturiaMay 29, 2024
	Rising Smoking Rates Among Teenage Girls: A Growing Health Crisis in IndiaMay 29, 2024
	WHO Launches $7 Billion Investment Round at the 77th World Health AssemblyMay 29, 2024
	From Insulin-Dependent to Insulin-Free in just 3 months: Game-Changing Diabetes Cure Developed by Chinese ScientistsMay 29, 2024

Search Results

Positive Results From ProDERM Study of octagamÂ® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020

Octapharma announces FDA approval of updated NUWIQÂ® Prescribing Information to include immunogenicity data in previously untreated patients

Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019

Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders

Update of Summary of Product Characteristics for NuwiqÂ® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis

Trending Now